Daratumumab Market Analysis by Indication (Multiple Myeloma, AL Amyloidosis), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Treatment Setting (Monotherapy, Combination Therapy) and by Region: Global Forecast, 2024 - 2034
- PUBLISHED ON
- 2024-05-03
- NO OF PAGES
- 241
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Daratumumab market is predicted to develop at a compound annual growth rate (CAGR) of XX% from 2024 to 2034, when it is projected to reach USD XX Million, based on an average growth pattern. The market is estimated to reach a value of USD XX Million in 2024.
Â
SOURCE: We Market Research
A monoclonal
antibody called Daratumumab is used to treat the cancerous disease known as
multiple myeloma. It helps destroy myeloma cells by targeting CD38, a protein
present on their surface. Daratumumab either directly destroys cancer cells by
attaching to CD38 or strengthens the immune system's defenses against them. It
has demonstrated efficacy in enhancing patient outcomes and is frequently used
in conjunction with other cancer therapy. Although Daratumumab selectively
targets cancer cells while causing the least amount of damage to healthy
organs, it represents a substantial development in the treatment of multiple myeloma
and gives patients hope.
The Daratumumab market is driven by a number of important variables worldwide. The increasing global prevalence of multiple myeloma is driving up demand for targeted treatments such as Daratumumab. Improvements in biotechnology, especially in the field of developing monoclonal antibodies, have made it possible to design more targeted and efficient therapeutic interventions. The market is also growing as a result of Daratumumab's extended approvals for diseases other than multiple myeloma, namely lymphoma and amyloidosis. Adoption of Daratumumab is further encouraged by strong clinical evidence demonstrating its safety and efficacy in multiple myeloma, particularly when used in combination treatments. Moreover, rising healthcare spending around the world promotes patient access to Daratumumab, which in turn promotes market sustainability and growth.Â
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD XX Million |
|
Market Forecast in 2034 |
USD XX Million |
|
CAGR % 2024-2034 |
XX% |
|
Base Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast Period |
2024-2034 |
|
Report USP Â |
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
|
Segments Covered |
by Indication, by Distribution Channel, by Treatment Setting and
By Region |
|
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia;
Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa;
Nigeria |
Â
Daratumumab Industry: Dynamics & Restrains
Market opportunity:
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Daratumumab Segmentation
Market- By Indication Analysis
By Indication, the Daratumumab Market is Categories into Multiple Myeloma, AL Amyloidosis. The Multiple Myeloma segment accounts for the largest share of around 68% in 2024.
Rising multiple myeloma incidence rates,
Daratumumab's clinical efficacy, regulatory approvals for the drug's use in
multiple myeloma, and the increasing need for efficient treatments to enhance
patient outcomes and quality of life are the factors driving the global market
for Daratumumab.
The
following segments are part of an in-depth analysis of the global Daratumumab
market:
|
Market Segments |
 |
|
By  Distribution
Channel |
·       Â
Hospital Pharmacies ·       Â
Retail Pharmacies ·       Â
Online Pharmacies |
|
By  End
User |
·       Â
Hospitals & Clinics ·       Â
Ambulatory Surgical Centers ·       Â
Cancer Research Centers |
|
By  Treatment
Setting |
·       Â
Monotherapy ·       Â
Combination Therapy |
Â
Daratumumab Industry: Regional Analysis
North America Market Forecast
North America dominate the Daratumumab Market with the highest revenue generating market with share of more than 48%. In North America the Daratumumab industry is driven by a robust healthcare infrastructure and the early uptake of novel medicines in the United States and Canada. The existence of significant pharmaceutical businesses dedicated to cancer therapies expedites the expansion of the industry.
Europe Market Statistics
Europe is the
second largest region in Daratumumab Market. The growth of the Daratumumab
market is driven by the rising incidence of multiple myeloma and the favorable
reimbursement practices in Germany and France. Academic institutions and
pharmaceutical corporations working together promote research and development,
which drives the market. Â
Asia Pacific Market Forecasts
Asia Pacific is
expected to be the fastest-growing regional segment of the Daratumumab market
during the forecast period. In the Asia Pacific region, the market for Daratumumab
is being driven by rising awareness of cancer treatment choices as well as
improved healthcare spending in China and Japan. The industry is growing as a
result of major player’s investments to increase their market presence in
developing nations like India.
Key Market PlayersÂ
The Daratumumab Market is dominated by a few
large companies, such as
·        Janssen Pharmaceuticals
·         Other
1.    Â
Global
Daratumumab Market Introduction and Market Overview
1.1.   Objectives of the Study
1.2.   Global Daratumumab Market Scope
and Market Estimation
1.2.1. Global Daratumumab Overall
Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2. Global Daratumumab Market
Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3.   Market Segmentation
1.3.1. Indication of Global Daratumumab
Market
1.3.2. Distribution Channel of Global Daratumumab
Market
1.3.3. End User of Global Daratumumab
Market
1.3.4. Treatment Setting of Global Daratumumab
Market
1.3.5. Region of Global Daratumumab
Market
2.    Â
Executive Summary
2.1.   Global Daratumumab Market Industry Trends under COVID-19 Outbreak
2.1.1. Global COVID-19 Status Overview
2.1.2. Influence of COVID-19 Outbreak
on Global Daratumumab Market
Industry Development
2.2.   Market Dynamics
2.2.1. Drivers
2.2.2. Limitations
2.2.3. Opportunities
2.2.4. Impact Analysis of Drivers and
Restraints
2.3.   Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.4.   Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.5.   Porter’s Five Forces Analysis
2.5.1. Bargaining Power of Suppliers
2.5.2. Bargaining Power of Buyers
2.5.3. Threat of Substitutes
2.5.4. Threat of New Entrants
2.5.5. Competitive Rivalry
2.6.   Value Chain / Ecosystem Analysis
2.7.   Russia-Ukraine War Impacts
Analysis
2.8.   Economic Downturn Analysis
2.9.     Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.    Â
Global Daratumumab Market Estimates & Historical Trend Analysis (2019 -
2023)
4.    Â
Global Daratumumab Market Estimates & Forecast Trend Analysis, by
INDICATION
4.1.   Global Daratumumab Market
Revenue (US$ Mn) Estimates and Forecasts, by INDICATION, 2019 to 2034
4.1.1. Multiple Myeloma
4.1.2. AL Amyloidosis
5.    Â
Global Daratumumab Market Estimates & Forecast Trend Analysis, by
Distribution Channel
5.1.   Global Daratumumab Market
Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034
5.1.1. Hospital Pharmacies
5.1.2. Retail Pharmacies
5.1.3. Online Pharmacies
6.    Â
Global Daratumumab Market Estimates & Forecast Trend Analysis, by
End-user
6.1.   Global Daratumumab Market
Revenue (US$ Mn) Estimates and Forecasts, by End-user,
2019 to 2034
6.1.1. Hospitals & Clinics
6.1.2. Ambulatory Surgical Centers
6.1.3. Cancer Research Centers
7.    Â
Global Daratumumab Market Estimates & Forecast Trend Analysis, by
TREATMENT SETTING
7.1.   Global Daratumumab Market
Revenue (US$ Mn) Estimates and Forecasts, by End-user,
2019 to 2034
7.1.1. Monotherapy
7.1.2. Combination Therapy
8.    Â
Global Daratumumab Market Estimates & Forecast Trend Analysis,
by Region
8.1.   Global Daratumumab Market
Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034
8.1.1. North America
8.1.2. Europe
8.1.3. Asia Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9.    Â
North
America Daratumumab Market: Estimates & Forecast Trend Analysis
9.1.  Â
North
America Daratumumab Market Assessments & Key Findings
9.1.1. North America Daratumumab Market
Introduction
9.1.2. North America Daratumumab Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1.  By INDICATION
9.1.2.2.  By Distribution
Channel
9.1.2.3.  By End-user
9.1.2.4.  By TREATMENT
SETTING
9.1.2.5.  By Country
9.1.2.5.1.    The U.S.
9.1.2.5.2.    Canada
9.1.2.5.3.    Mexico
10. Europe Daratumumab
Market: Estimates & Forecast Trend
Analysis
10.1. Europe Daratumumab Market
Assessments & Key Findings
10.1.1.  Europe Daratumumab Market
Introduction
10.1.2.  Europe Daratumumab Market Size
Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1.   By INDICATION
10.1.2.2.   By Distribution
Channel
10.1.2.3.   By End-user
10.1.2.4.   By TREATMENT
SETTING
10.1.2.5.   By Country
10.1.2.5.1. Germany
10.1.2.5.2. U.K.
10.1.2.5.3. France
10.1.2.5.4. Italy
10.1.2.5.5. Spain
10.1.2.5.6. Russia
10.1.2.5.7. Rest of Europe
11. Asia Pacific Daratumumab
Market: Estimates & Forecast Trend
Analysis
11.1. Asia Pacific Market Assessments
& Key Findings
11.1.1.  Asia Pacific Daratumumab Market
Introduction
11.1.2.  Asia Pacific Daratumumab Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1.   By INDICATION
11.1.2.2.   By Distribution
Channel
11.1.2.3.   By End-user
11.1.2.4.   By TREATMENT
SETTING
11.1.2.5.   By Country
11.1.2.5.1. China
11.1.2.5.2. Japan
11.1.2.5.3. India
11.1.2.5.4. Australia
11.1.2.5.5. South Korea
11.1.2.5.6. ASEAN
11.1.2.5.7. Rest of Asia Pacific
12. Middle East & Africa Daratumumab
Market: Estimates & Forecast Trend
Analysis
12.1. Middle East & Africa Market
Assessments & Key Findings
12.1.1.  Middle
East & Africa Daratumumab
Market Introduction
12.1.2.  Middle
East & Africa Daratumumab
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1.   By INDICATION
12.1.2.2.   By Distribution
Channel
12.1.2.3.   By End-user
12.1.2.4.   By TREATMENT
SETTING
12.1.2.5.   By Country
12.1.2.5.1. U.A.E.
12.1.2.5.2. Saudi Arabia
12.1.2.5.3. Egypt
12.1.2.5.4. South Africa
12.1.2.5.5. Rest of Middle East & Africa
13. South America
Daratumumab Market: Estimates &
Forecast Trend Analysis
13.1. South America Market Assessments
& Key Findings
13.1.1.  South America Daratumumab Market
Introduction
13.1.2.  South America Daratumumab Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
13.1.2.1.   By INDICATION
13.1.2.2.   By Distribution
Channel
13.1.2.3.   By End-user
13.1.2.4.   By TREATMENT
SETTING
13.1.2.5.   By Country
13.1.2.5.1. Brazil
13.1.2.5.2. Argentina
13.1.2.5.3. Colombia
13.1.2.5.4. Rest of South America
14. Competition Landscape
14.1. Global Daratumumab Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
14.2. Global Daratumumab Market
Competition White Space Analysis, By End-user
14.3. Global Daratumumab Market
Competition Heat Map Analysis, By End-user
14.4. Global Daratumumab Market
Concentration & Company Market Shares (%) Analysis, 2022
15. Company Profiles
15.1.                   Â
Janssen Pharmaceuticals
15.1.1.  .Company Overview & Key Stats
15.1.2.  Financial Performance & KPIs
15.1.3.  Product Portfolio
15.1.4.  Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned belowÂ
15.2.     Others
16. Research
Methodology
16.1. External Transportations /
Databases
16.2. Internal Proprietary Database
16.3. Primary Research
16.4. Secondary Research
16.5. Assumptions
16.6. Limitations
16.7. Report FAQs
17. Research Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Daratumumab Market in 2024?
Daratumumab Market was valued at USD XX Million in 2024.
What is the growth rate for the Daratumumab Market?
Daratumumab Market size will increase at approximate CAGR of XX% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Daratumumab Market is Janssen Pharmaceuticals and Other.
Which region dominates the Daratumumab Market?
North America dominates the market with an active share of 48%.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI